Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 6 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 26, 2020 Filed Jan 28, 2020 22:10 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units (RSUs) · Derivative | 833 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-005200 · doc4.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,667 Underlying: Ordinary Shares · 833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. F4 · derivative.exercise_date: The reporting person was granted 2,500 Restricted Stock Units ("RSUs") on January 26, 2019. 33.33% of the RSUs vested on January 26, 2020 and 12.5% of the remaining RSUs will vest in eight equal quarterly installments thereafter. F4 · derivative.expiration_date: The reporting person was granted 2,500 Restricted Stock Units ("RSUs") on January 26, 2019. 33.33% of the RSUs vested on January 26, 2020 and 12.5% of the remaining RSUs will vest in eight equal quarterly installments thereafter. Read SEC document |
| January 26, 2020 Filed Jan 28, 2020 22:10 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-005200 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,499 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 26, 2020 Filed Jan 28, 2020 22:15 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
Exercise / conversionRestricted Stock Units (RSUs) · Derivative | 1,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-005215 · doc4.xml · derivative · entry 3 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,334 Underlying: Ordinary Shares · 1,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted 5,000 Restricted Stock Units ("RSUs") on January 26, 2019. 33.33% of the RSUs vested on January 26, 2020 and 12.5% of the remaining RSUs will vest in eight equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted 5,000 Restricted Stock Units ("RSUs") on January 26, 2019. 33.33% of the RSUs vested on January 26, 2020 and 12.5% of the remaining RSUs will vest in eight equal quarterly installments thereafter. Read SEC document |
| January 26, 2020 Filed Jan 28, 2020 22:15 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
Exercise / conversionOrdinary Shares | 1,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-005215 · doc4.xml · nonDerivative · entry 1 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,105 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 26, 2020 Filed Jan 28, 2020 22:14 UTC |
Mullennix StephenChief Operating Officer
|
Exercise / conversionRestricted Stock Units (RSUs) · Derivative | 1,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-005211 · doc4.xml · derivative · entry 3 Mullennix Stephen · CIK 0001764139 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,334 Underlying: Ordinary Shares · 1,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted 5,000 Restricted Stock Units ("RSUs") on January 26, 2019. 33.33% of the RSUs vested on January 26, 2020 and 12.5% of the remaining RSUs will vest in eight equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted 5,000 Restricted Stock Units ("RSUs") on January 26, 2019. 33.33% of the RSUs vested on January 26, 2020 and 12.5% of the remaining RSUs will vest in eight equal quarterly installments thereafter. Read SEC document |
| January 26, 2020 Filed Jan 28, 2020 22:14 UTC |
Mullennix StephenChief Operating Officer
|
Exercise / conversionOrdinary Shares | 1,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-005211 · doc4.xml · nonDerivative · entry 1 Mullennix Stephen · CIK 0001764139 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,349 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 23:30 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionOrdinary Shares · Derivative | 105,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-002366 · doc4.xml · derivative · entry 2 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,377 Underlying: Ordinary Shares · 105,688 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: On January 3, 2018, the reporting person was granted 317,065 restricted stock units of which 33% vested on January 3, 2020. The remaining unvested restricted stock units will vest at a rate of 2.778% in equal monthly installments thereafter. F3 · derivative.expiration_date: On January 3, 2018, the reporting person was granted 317,065 restricted stock units of which 33% vested on January 3, 2020. The remaining unvested restricted stock units will vest at a rate of 2.778% in equal monthly installments thereafter. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 23:30 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 105,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-002366 · doc4.xml · nonDerivative · entry 1 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,236 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the settlement of restricted stock units that vested on January 3, 2020 through the issuance of ordinary shares. Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 18:44 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units (RSUs) · Derivative | 1,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-059250 · doc4.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,167 Underlying: Ordinary Shares · 1,042 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. F3 · kind: The transaction reported herein was matchable under Section 16(b) of the Securities and Exchange Act of 1934, to the extent of 343 shares, with the reporting person's purchase of 1,960 ordinary shares of the Issuer at a price of $28.17 per share on November 19, 2019. The reporting person has paid to the Issuer $1,207.36, representing the full amount of the profit realized in connection with the short-swing transaction. F4 · derivative.exercise_date: On December 7, 2017, the reporting person was granted restricted stock units ("RSUs") representing 12,500 ordinary shares. 1/3rd of the RSUs vested on December 4, 2018, with the balance vesting in equal quarterly installments thereafter over a period of three years. F4 · derivative.expiration_date: On December 7, 2017, the reporting person was granted restricted stock units ("RSUs") representing 12,500 ordinary shares. 1/3rd of the RSUs vested on December 4, 2018, with the balance vesting in equal quarterly installments thereafter over a period of three years. Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 18:44 UTC |
Schoenberg MarkChief Medical Officer
|
Tax withholdingOrdinary Shares | 343 | $31.69 | $10,869.67 |
DisclosureSEC source: 0001209191-19-059250 · doc4.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,666 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 18:44 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 1,042 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-059250 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,009 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 20:34 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
PurchaseOrdinary Shares | 7,530 | $28.00 | $210,840.00 |
DisclosureSEC source: 0001209191-19-057766 · doc4.xml · nonDerivative · entry 1 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,548 Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 18:35 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
PurchaseOrdinary Shares | 7,470 | $28.00 | $209,160.00 |
DisclosureSEC source: 0001209191-19-057755 · doc4.xml · nonDerivative · entry 1 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,018 Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 18:29 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-057753 · doc4.xml · derivative · entry 3 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,291 Underlying: Ordinary Shares · 1,042 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on July 19, 2018 representing 12,500 ordinary shares. 33.33% of the RSUs vested on August 20, 2019 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on July 19, 2018 representing 12,500 ordinary shares. 33.33% of the RSUs vested on August 20, 2019 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 18:29 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
SaleOrdinary Shares | 354 | $28.41 | $10,057.14 |
DisclosureSEC source: 0001209191-19-057753 · doc4.xml · nonDerivative · entry 2 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,439 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 18:29 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
Exercise / conversionOrdinary Shares | 1,042 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-057753 · doc4.xml · nonDerivative · entry 1 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| November 19, 2019 Filed Nov 22, 2019 01:49 UTC |
Schoenberg MarkChief Medical Officer
|
PurchaseOrdinary Shares | 1,960 | $28.17 | $55,213.20 |
DisclosureSEC source: 0001209191-19-057692 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Mark Schoenberg Pension Plan FBO Mark Schoenberg Disclosed balance after: 7,967 Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 00:32 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
PurchaseOrdinary Shares | 1,548 | $26.00 | $40,248.00 |
DisclosureSEC source: 0001209191-19-057044 · doc4.xml · nonDerivative · entry 1 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,548 Read SEC document |
| November 14, 2019 Filed Nov 18, 2019 21:04 UTC |
Mullennix StephenChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-056923 · doc4.xml · derivative · entry 3 Mullennix Stephen · CIK 0001764139 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,796 Underlying: Ordinary Shares · 1,759 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on March 7, 2018, June 4, 2018 and October 28, 2018 representing 21,107 ordinary shares in the aggregate. 1/3rd of the RSUs vested on February 14, 2019, with the balance vesting in equal quarterly installments thereafter over a period of two years. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on March 7, 2018, June 4, 2018 and October 28, 2018 representing 21,107 ordinary shares in the aggregate. 1/3rd of the RSUs vested on February 14, 2019, with the balance vesting in equal quarterly installments thereafter over a period of two years. Read SEC document |
| November 14, 2019 Filed Nov 18, 2019 21:04 UTC |
Mullennix StephenChief Operating Officer
|
SaleOrdinary Shares | 608 | $26.00 | $15,806.36 |
DisclosureSEC source: 0001209191-19-056923 · doc4.xml · nonDerivative · entry 2 Mullennix Stephen · CIK 0001764139 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,683 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| November 14, 2019 Filed Nov 18, 2019 21:04 UTC |
Mullennix StephenChief Operating Officer
|
Exercise / conversionOrdinary Shares | 1,759 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-056923 · doc4.xml · nonDerivative · entry 1 Mullennix Stephen · CIK 0001764139 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,291 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| September 04, 2019 Filed Sep 6, 2019 13:27 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units (RSUs) · Derivative | 1,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-048672 · doc4.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,209 Underlying: Ordinary Shares · 1,041 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: On December 7, 2017, the reporting person was granted restricted stock units ("RSUs") representing 12,500 ordinary shares. 1/3rd of the RSUs vested on December 4, 2018, with the balance vesting in equal quarterly installments thereafter over a period of two years. F3 · derivative.expiration_date: On December 7, 2017, the reporting person was granted restricted stock units ("RSUs") representing 12,500 ordinary shares. 1/3rd of the RSUs vested on December 4, 2018, with the balance vesting in equal quarterly installments thereafter over a period of two years. Read SEC document |
| September 04, 2019 Filed Sep 6, 2019 13:27 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 343 | $33.92 | $11,634.56 |
DisclosureSEC source: 0001209191-19-048672 · doc4.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,007 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| September 04, 2019 Filed Sep 6, 2019 13:27 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 1,041 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-048672 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 17:31 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-047107 · doc4.xml · derivative · entry 3 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,333 Underlying: Ordinary Shares · 4,167 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on July 19, 2018 representing 12,500 ordinary shares. 33.33% of the RSUs will vest on August 20, 2019 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on July 19, 2018 representing 12,500 ordinary shares. 33.33% of the RSUs will vest on August 20, 2019 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 17:31 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
SaleOrdinary Shares | 1,416 | $33.07 | $46,827.12 |
DisclosureSEC source: 0001209191-19-047107 · doc4.xml · nonDerivative · entry 2 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,751 F2 · balance_after: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 17:31 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
Exercise / conversionOrdinary Shares | 4,167 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-047107 · doc4.xml · nonDerivative · entry 1 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 19:38 UTC |
Mullennix StephenChief Operating Officer
|
SaleOrdinary Shares | 608 | $31.65 | $19,243.20 |
DisclosureSEC source: 0001209191-19-046282 · doc4.xml · nonDerivative · entry 2 Mullennix Stephen · CIK 0001764139 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,532 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| August 14, 2019 Filed Aug 16, 2019 19:38 UTC |
Mullennix StephenChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-046282 · doc4.xml · derivative · entry 3 Mullennix Stephen · CIK 0001764139 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,555 Underlying: Ordinary Shares · 1,759 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on March 7, 2018, June 4, 2018 and October 28, 2018 representing 21,107 ordinary shares in the aggregate. 1/3rd of the RSUs vested on February 14, 2019, with the balance vesting in equal quarterly installments thereafter over a period of two years. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on March 7, 2018, June 4, 2018 and October 28, 2018 representing 21,107 ordinary shares in the aggregate. 1/3rd of the RSUs vested on February 14, 2019, with the balance vesting in equal quarterly installments thereafter over a period of two years. Read SEC document |
| August 14, 2019 Filed Aug 16, 2019 19:38 UTC |
Mullennix StephenChief Operating Officer
|
Exercise / conversionOrdinary Shares | 1,759 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-046282 · doc4.xml · nonDerivative · entry 1 Mullennix Stephen · CIK 0001764139 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,140 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 22:21 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units (RSUs) · Derivative | 1,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-035245 · doc4.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Ordinary Shares · 1,042 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: On December 7, 2017, the reporting person was granted restricted stock units ("RSUs") representing 12,500 ordinary shares. 1/3rd of the RSUs vested on December 4, 2018, with the balance vesting in equal quarterly installments thereafter over a period of two years. F3 · derivative.expiration_date: On December 7, 2017, the reporting person was granted restricted stock units ("RSUs") representing 12,500 ordinary shares. 1/3rd of the RSUs vested on December 4, 2018, with the balance vesting in equal quarterly installments thereafter over a period of two years. Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 22:21 UTC |
Schoenberg MarkChief Medical Officer
|
Tax withholdingOrdinary Shares | 343 | $35.05 | $12,022.15 |
DisclosureSEC source: 0001209191-19-035245 · doc4.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,309 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 22:21 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 1,042 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-035245 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 16:54 UTC |
Holden StuartDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $34.83 | $0.00 |
DisclosureSEC source: 0001209191-19-034780 · doc4.xml · derivative · entry 1 Holden Stuart · CIK 0001763999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2019-06-02 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of two years. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 20:52 UTC |
Belldegrun ArieDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $34.83 | $0.00 |
DisclosureSEC source: 0001209191-19-034777 · doc4.xml · derivative · entry 1 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2029-06-02 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of two years. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 21:02 UTC |
Tomasello ShawnDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $34.83 | $0.00 |
DisclosureSEC source: 0001209191-19-034793 · doc4.xml · derivative · entry 1 Tomasello Shawn · CIK 0001617239 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2029-06-02 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of two years. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 20:59 UTC |
FALBERG KATHRYN EDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $34.83 | $0.00 |
DisclosureSEC source: 0001209191-19-034790 · doc4.xml · derivative · entry 1 FALBERG KATHRYN E · CIK 0001206977 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2029-06-02 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of two years. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 20:58 UTC |
BUTITTA CYNTHIA MDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $34.83 | $0.00 |
DisclosureSEC source: 0001209191-19-034788 · doc4.xml · derivative · entry 1 BUTITTA CYNTHIA M · CIK 0001222082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2029-06-02 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of two years. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 20:57 UTC |
Cohen Fred EDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $34.83 | $0.00 |
DisclosureSEC source: 0001209191-19-034787 · doc4.xml · derivative · entry 1 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2029-06-02 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of two years. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 20:55 UTC |
Nussbaum RanDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $34.83 | $0.00 |
DisclosureSEC source: 0001209191-19-034785 · doc4.xml · derivative · entry 1 Nussbaum Ran · CIK 0001609805 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2029-06-02 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of two years. Read SEC document |
| May 14, 2019 Filed May 16, 2019 22:20 UTC |
Mullennix StephenChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-030594 · doc4.xml · derivative · entry 3 Mullennix Stephen · CIK 0001764139 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,314 Underlying: Ordinary Shares · 1,759 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on March 7, 2018, June 4, 2018 and October 28, 2018 representing 21,107 ordinary shares in the aggregate. 1/3rd of the RSUs vested on February 14, 2019, with the balance vesting in equal quarterly installments thereafter over a period of two years. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on March 7, 2018, June 4, 2018 and October 28, 2018 representing 21,107 ordinary shares in the aggregate. 1/3rd of the RSUs vested on February 14, 2019, with the balance vesting in equal quarterly installments thereafter over a period of two years. Read SEC document |
| May 14, 2019 Filed May 16, 2019 22:20 UTC |
Mullennix StephenChief Operating Officer
|
SaleOrdinary Shares | 608 | $37.98 | $23,091.84 |
DisclosureSEC source: 0001209191-19-030594 · doc4.xml · nonDerivative · entry 2 Mullennix Stephen · CIK 0001764139 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,381 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| May 14, 2019 Filed May 16, 2019 22:20 UTC |
Mullennix StephenChief Operating Officer
|
Exercise / conversionOrdinary Shares | 1,759 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-030594 · doc4.xml · nonDerivative · entry 1 Mullennix Stephen · CIK 0001764139 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 20:52 UTC |
Belldegrun ArieDirector
|
Exercise / conversionStock Option (right to buy · Derivative | 128,000 | $4.02 Strike: $4.02 | $514,560.00 |
DisclosureSEC source: 0001209191-19-021635 · doc4.xml · derivative · entry 2 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 128,000 shares Expires 2019-10-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the shares underlying the stock option vested on each of October 13, 2012, October 13, 2013, October 13, 2014 and October 13, 2015. Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 20:52 UTC |
Belldegrun ArieDirector
|
Exercise / conversionOrdinary Shares | 128,000 | $4.02 | $514,560.00 |
DisclosureSEC source: 0001209191-19-021635 · doc4.xml · nonDerivative · entry 1 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,211 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 21, 2019 Filed Mar 22, 2019 23:42 UTC |
Schoenberg MarkChief Medical Officer
|
PurchaseOrdinary Shares | 272 | $37.01 | $10,066.45 |
DisclosureSEC source: 0001209191-19-021092 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,610 F1 · kind: The reporting person's purchase of Ordinary Shares of the Issuer reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the reporting person's sale of 272 Ordinary Shares of the Issuer at a price of $37.30 per share on March 6, 2019. The reporting person has agreed to pay to the Issuer $79.15, representing the full amount of the profit realized in connection with the short-swing transaction. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 02:46 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 1,991 | $37.30 | $74,264.30 |
DisclosureSEC source: 0001209191-19-017933 · doc4.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,338 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| March 04, 2019 Filed Mar 8, 2019 02:46 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units (RSUs) · Derivative | 1,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-017933 · doc4.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,292 Underlying: Ordinary Shares · 1,042 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: On December 7, 2017, the reporting person was granted restricted stock units ("RSUs") representing 12,500 ordinary shares. 1/3rd of the RSUs vested on December 4, 2018, with the balance vesting in equal quarterly installments thereafter over a period of two years, with the issuance of the underlying shares for the March 4, 2019 installment delayed until March 5, 2019. F3 · derivative.expiration_date: On December 7, 2017, the reporting person was granted restricted stock units ("RSUs") representing 12,500 ordinary shares. 1/3rd of the RSUs vested on December 4, 2018, with the balance vesting in equal quarterly installments thereafter over a period of two years, with the issuance of the underlying shares for the March 4, 2019 installment delayed until March 5, 2019. Read SEC document |
| March 04, 2019 Filed Mar 8, 2019 02:46 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 1,042 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-017933 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,329 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| February 14, 2019 Filed Mar 8, 2019 02:44 UTC |
Mullennix StephenChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 7,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-017932 · doc4.xml · derivative · entry 3 Mullennix Stephen · CIK 0001764139 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,073 Underlying: Ordinary Shares · 7,034 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on March 7, 2018, June 4, 2018 and October 28, 2018 representing 21,107 ordinary shares in the aggregate. 1/3rd of the RSUs vested on February 14, 2019 (with the issuance of the underlying ordinary shares delayed until March 5, 2019), with the balance vesting in equal quarterly installments thereafter over a period of two years. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on March 7, 2018, June 4, 2018 and October 28, 2018 representing 21,107 ordinary shares in the aggregate. 1/3rd of the RSUs vested on February 14, 2019 (with the issuance of the underlying ordinary shares delayed until March 5, 2019), with the balance vesting in equal quarterly installments thereafter over a period of two years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.